Rebalance LLC purchased a new stake in shares of iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report) in the 4th quarter, HoldingsChannel reports. The firm purchased 358,509 shares of the company’s stock, valued at approximately $8,590,000. iShares iBonds Dec 2027 Term Corporate ETF makes up 0.6% of Rebalance LLC’s portfolio, making the stock its 16th largest holding.
Other large investors have also bought and sold shares of the company. Valley Wealth Managers Inc. boosted its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 0.7% during the third quarter. Valley Wealth Managers Inc. now owns 74,118 shares of the company’s stock valued at $1,806,000 after buying an additional 494 shares during the last quarter. Horizons Wealth Management increased its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF by 12.2% in the fourth quarter. Horizons Wealth Management now owns 8,641 shares of the company’s stock worth $207,000 after purchasing an additional 941 shares in the last quarter. Harbor Investment Advisory LLC lifted its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF by 2.7% during the 4th quarter. Harbor Investment Advisory LLC now owns 40,550 shares of the company’s stock valued at $972,000 after buying an additional 1,077 shares in the last quarter. Confluence Investment Management LLC boosted its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF by 0.8% in the fourth quarter. Confluence Investment Management LLC now owns 165,459 shares of the company’s stock worth $3,964,000 after acquiring an additional 1,370 shares during the period. Finally, Roble Belko & Company Inc boosted its stake in iShares iBonds Dec 2027 Term Corporate ETF by 10.2% in the 4th quarter. Roble Belko & Company Inc now owns 15,865 shares of the company’s stock worth $380,000 after purchasing an additional 1,466 shares during the period.
iShares iBonds Dec 2027 Term Corporate ETF Trading Down 0.1 %
iShares iBonds Dec 2027 Term Corporate ETF stock opened at $24.08 on Monday. iShares iBonds Dec 2027 Term Corporate ETF has a 1 year low of $23.44 and a 1 year high of $24.68. The firm’s 50 day moving average price is $24.02 and its 200-day moving average price is $24.10.
About iShares iBonds Dec 2027 Term Corporate ETF
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.
See Also
- Five stocks we like better than iShares iBonds Dec 2027 Term Corporate ETF
- Investing In Automotive Stocks
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- How to Calculate Return on Investment (ROI)
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- What Does a Stock Split Mean?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding IBDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report).
Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.